Federal contract award
M0026424F0340
CLIN: 0003, DELIVERABLE: 3, FUNCTIONAL AREA: CURRENT OPS AND INTEL STUDIES, TASK: TECHNOLOGY FORECASTING ANALYSIS, LOW COMPLEXITY, AND RELATED TRAVEL COSTS UNDER CLIN 0007, TRAVEL, FOR ORDERING PERIOD 1
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | COMMANDER |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | B599 — Other Special Studies and Analysis |
| Parent award / vehicle | M0026424D0001 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $163.6K |
| Current contract value | $163.6K |
| Potential contract value / ceiling | $163.6K |
| Start date | Sep 17, 2024 |
| Current end date | Mar 16, 2025 |
| Potential end date | Mar 16, 2025 |
| Latest award activity | May 12, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 12, 2025 | P00002 | $0 | ADM MOD: CLIN: 0003, DELIVERABLE: 3, FUNCTIONAL AREA: CURRENT OPS AND INTEL STUDIES, TASK: TECHNOLOGY FORECASTING ANALYSIS, LOW COMPLEXITY AND RELATED TRAVEL COSTS UNDER CLIN 0007, TRAVEL, FOR ORDERING PERIOD 1 |
| Jan 21, 2025 | P00001 | $0 | ADM MOD: CLIN: 0003, DELIVERABLE: 3, FUNCTIONAL AREA: CURRENT OPS AND INTEL STUDIES, TASK: TECHNOLOGY FORECASTING ANALYSIS, LOW COMPLEXITY AND RELATED TRAVEL COSTS UNDER CLIN 0007, TRAVEL, FOR ORDERING PERIOD 1 |
| Sep 17, 2024 | 0 | $163.6K | CLIN: 0003, DELIVERABLE: 3, FUNCTIONAL AREA: CURRENT OPS AND INTEL STUDIES, TASK: TECHNOLOGY FORECASTING ANALYSIS, LOW COMPLEXITY, AND RELATED TRAVEL COSTS UNDER CLIN 0007, TRAVEL, FOR ORDERING PERIOD 1 |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.